TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥6,315,407 | ¥5,774,086 | ¥3,034,863 | ¥4,480,753 |
| Dep. & Amort. | ¥715,426 | ¥676,163 | ¥639,973 | ¥567,237 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥823,198 | ¥1,669,065 | -¥3,264,269 | -¥231,133 |
| Other Non-Cash | -¥1,035,559 | ¥1,815,760 | -¥3,568,173 | ¥5,877,831 |
| Operating Cash Flow | ¥6,818,472 | ¥9,935,074 | -¥3,157,606 | ¥10,694,688 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥5,121,372 | -¥3,753,177 | -¥1,165,613 | -¥2,300,025 |
| Net Acquisitions | ¥5,085 | -¥150,000 | -¥298,665 | ¥55 |
| Inv. Purchases | -¥4,141,797 | -¥151,279 | -¥150,960 | -¥381,300 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | ¥0 | -¥55,926 | -¥1 | ¥1,400 |
| Investing Cash Flow | -¥9,258,084 | -¥4,110,382 | -¥1,615,239 | -¥2,679,870 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥4,885,001 | ¥2,966,620 | ¥1,568,000 | -¥1,860,000 |
| Stock Issued | ¥178,782 | ¥5,681 | ¥1,800 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥2,782,432 | -¥600,000 | -¥1,900,000 | -¥1,800,000 |
| Other Fin. Act. | -¥1 | -¥16,478 | ¥0 | ¥0 |
| Financing Cash Flow | ¥2,281,350 | ¥2,355,823 | -¥330,200 | -¥3,660,000 |
| Forex Effect | ¥1 | ¥1 | ¥0 | ¥1,992,602 |
| Net Chg. in Cash | -¥158,261 | ¥8,180,516 | -¥5,103,045 | ¥6,339,138 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥9,424,891 | ¥1,244,375 | ¥6,347,420 | ¥8,282 |
| End Cash | ¥9,266,630 | ¥9,424,891 | ¥1,244,375 | ¥6,347,420 |
| Free Cash Flow | ¥2,137,453 | ¥5,973,875 | -¥4,323,219 | ¥8,394,663 |